Literature DB >> 16844596

Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation.

F Fernández-Bañares1, M Esteve-Comas, J Mañé, E Navarro, X Bertrán, E Cabré, R Bartolí, J Boix, C Pastor, M A Gassull.   

Abstract

BACKGROUND AND AIMS: Plasma polyunsaturated fatty acid profile in patients with inflammatory bowel disease is abnormal. We aimed to assess the mucosal fatty acid pattern in patients with ulcerative colitis and Crohn's disease, and in rats with trinitrobenzene-sulfonic acid (TNB) induced colitis.
METHODS: Fatty acids were measured in colonic mucosa of patients with ulcerative colitis (n = 30), Crohn's disease (n = 21), and healthy controls (n = 13). Likewise, they were assessed in the colonic mucosa of rats with TNB- and sham-colitis.
RESULTS: There was an increase of the end-products (C22:5n3, C22:6n3, C20:4n6, C22:5n6) and a decrease of the precursors (C18:3n3, C18:2n6) of both n3 and n6 polyunsaturated fatty acids in the mucosa of active ulcerative colitis and TNB-colitis. Also, high values of saturated (C16:0, C18:0) and low values of monounsaturated fatty acids (C18:1n9) were observed. Furthermore, the mucosa of active Crohn's disease showed substantial changes in saturated, monounsaturated and essential fatty acids, but not in polyunsaturated fatty acids. Mucosa of patients with inactive disease showed intermediate fatty acid values between the mucosa of active patients and healthy controls.
CONCLUSIONS: Colonic inflammation causes a characteristic modification of the mucosal fatty acid profile which appears to be common to different aetiologies and seems to be related to the degree of inflammation.

Entities:  

Year:  1997        PMID: 16844596     DOI: 10.1016/s0261-5614(97)80003-9

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  12 in total

Review 1.  Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.

Authors:  M-I Torres; A Rios
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

Review 2.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

3.  Dietary fat intake and inflammatory bowel disease.

Authors:  M A Gassull
Journal:  Curr Gastroenterol Rep       Date:  2001-08

4.  Metabolomics reveals metabolic biomarkers of Crohn's disease.

Authors:  Janet Jansson; Ben Willing; Marianna Lucio; Ages Fekete; Johan Dicksved; Jonas Halfvarson; Curt Tysk; Philippe Schmitt-Kopplin
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

5.  The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease.

Authors:  J Schwarz; M Vecka; F Stožický; R Pomahačová; B Staňková; E Tvrzická; M Kreslová; R Zahálková; J Sýkora
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

6.  Diversity of Gut Microbiota Metabolic Pathways in 10 Pairs of Chinese Infant Twins.

Authors:  Shaoming Zhou; Ruihuan Xu; Fusheng He; Jiaxiu Zhou; Yan Wang; Jianli Zhou; Mingbang Wang; Wenhao Zhou
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Transcriptomics-driven lipidomics (TDL) identifies the microbiome-regulated targets of ileal lipid metabolism.

Authors:  Anirikh Chakrabarti; Mathieu Membrez; Delphine Morin-Rivron; Jay Siddharth; Chieh Jason Chou; Hugues Henry; Stephen Bruce; Sylviane Metairon; Frederic Raymond; Bertrand Betrisey; Carole Loyer; Scott J Parkinson; Mojgan Masoodi
Journal:  NPJ Syst Biol Appl       Date:  2017-11-07

8.  Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells.

Authors:  Julian D Ramakers; Ronald P Mensink; Gert Schaart; Jogchum Plat
Journal:  Lipids       Date:  2007-07-03       Impact factor: 1.880

9.  Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis.

Authors:  Dawn M Wiese; Sara N Horst; Caroline T Brown; Margaret M Allaman; Mallary E Hodges; James C Slaughter; Jennifer P Druce; Dawn B Beaulieu; David A Schwartz; Keith T Wilson; Lori A Coburn
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

10.  Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.

Authors:  Thomas Lee; Thomas Clavel; Kirill Smirnov; Annemarie Schmidt; Ilias Lagkouvardos; Alesia Walker; Marianna Lucio; Bernhard Michalke; Philippe Schmitt-Kopplin; Richard Fedorak; Dirk Haller
Journal:  Gut       Date:  2016-02-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.